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H I G H L I G H T S
 C8-PhIP-dG adducts were quantiﬁed in hSULT mice by the sensitive method UPLC–MS/MS.
 hSULT mice had a 3-14-fold increase in adducts of liver, kidney and intestine.
 UPLC–MS/MS proves to be a reproducible and sensitive detection method for adducts.
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A B S T R A C T
Food processing contaminant 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) has previously
been shown to induce formation of DNA adducts in vivo. In a previous study the adduct levels were found
to increase in a mouse model expressing human (h) sulfotransferases (SULTs) 1A1 and 1A2 after PhIP
exposure, detected by 32P-postlabelling. Isotope dilution ultra performance liquid chromatography
coupled with tandem mass spectrometry (UPLC–MS/MS) is emerging as the method of choice for
selective and reproducible detection of known DNA adducts. In the present study we investigated the
level and distribution of PhIP induced DNA adducts in male FVB mice 9–11 weeks of age with hSULT mice
or wild-type mice (wt) using UPLC–MS/MS. Mice received a single administration of 75 mg/kg bw PhIP by
oral gavage, and DNA was analysed 3 h after exposure. C8-(2-amino-1-methyl-6-phenylimidazo[4,5-b]
pyridine- N2-yl)-20-deoxyguanosine (C8-PhIP-dG) adduct levels are signiﬁcantly higher in PhIP exposed
hSULT mice compared with PhIP exposed wt mice. The liver was the least affected organ in wild-type
mice, whereas it was the most affected organ in hSULT mice with a 14-fold higher adduct level.
ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Toxicology Letters
journal homepage: www.elsev ier .com/locate / tox let1. Introduction
Heat treatment of food leads to the generation of numerous
compounds that were not present in the raw material; among
these is the heterocyclic amine 2-amino-1-methyl-6-Abbreviations: CYP, cytochrome P450; 20-deoxyguanosine-PhIP, C8-(2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine-N2-yl)-20-deoxyguanosine; h, human;
hSULT mice, FVB mice expressing human sulfotransferases 1A1 and 1A2; NAT, N-
acetyltransferase; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; SULT,
sulfotransferase; UPLC–MS/MS, ultra performance liquid chromatography coupled
with tandem mass spectrometry.
* Corresponding author.
E-mail address: trine.husoy@fhi.no (T. Husøy).
http://dx.doi.org/10.1016/j.toxlet.2016.02.017
0378-4274/ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/4.0/).phenylimidazo[4,5-b]pyridine (PhIP). This food processing con-
taminant was discovered in 1986 and found to be mutagenic in the
Ames test in the presence of a metabolic activation system (Felton
et al., 1986). It also demonstrated carcinogenic activity in rodents
(Ito et al., 1997 Sugimura, 1997) and was classiﬁed as “possibly
carcinogenic to humans” by the International Agency for Research
on Cancer (IARC, 1993). PhIP is one of the most abundant
heterocyclic amines in foods, reaching levels of ng/g in heat
treated meat, ﬁsh and poultry (Knize et al., 2002; Skog and
Solyakov, 2002).
PhIP in its original form is not mutagenic, and bioactivation
requires a two-step process. The ﬁrst step is hydroxylation of the
exocyclic amine group by cytochrome P450 (CYP), especially
CYP1A2, which produces N-OH-PhIP (Snyderwine et al., 2002).article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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ases (SULTs) or N-acetyltransferases (NATs) to become esters that
go through heterolytic cleavage to produce a reactive nitrenium
ion, which may bind to DNA (Frandsen et al., 1992). In humans,
SULT1As are enzymes with high capacity to transform N-OH-PhIP
into reactive compounds. The importance of human (h)
SULT1A1 was demonstrated when the mutagenicity of N-OH-PhIP
was strongly increased in a recombinant Salmonella typhimurium
strain expressing hSULT1A1 compared with the parental strain, but
also compared with recombinant strains expressing NATs (Muckel
et al., 2002). Homozygous FVB/N mice expressing multiple copies
of the human SULT1A1–1A2 gene cluster was generated. The level
of hSULT1A1 protein in the cytosolic tissue fraction was found to be
10–100 times higher than in human tissue. Furthermore, the
sulphating activities of the cytosolic tissue preparation were
roughly ten times higher in the transgenic mice compared to wt
mice (Dobbernack et al., 2011). Previously, in transgenic mice
hemizygous for the expression of hSULT1A1 and 1A2, oral PhIP
administration substantially elevated the adduct level compared to
wt mice (Dobbernack et al., 2011). Adducts were measured by 32P-
postlabelling method. However, this method has limitations
regarding speciﬁcity and there is a risk of underestimating the
adduct levels. For this reason, highly speciﬁc liquid chromatogra-
phy and mass spectrometry based approaches using internal
reference compounds have become the method of choice for the
accurate and reproducible detection of chemically deﬁned adducts
(Farmer and Singh, 2008; Monien, 2014). Such methods have
previously successfully quantitated PhIP induced DNA adducts in
vivo (Goodenough et al., 2007; Singh et al., 1988).
In the present study, we aimed at quantifying C8-(2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine- N2-yl)-20-deoxyguano-
sine (C8-PhIP-dG) adducts in organs of mice expressing
hSULT1A1 and 1A2 after oral administration of PhIP, using the
more reproducible and sensitive method isotope-dilution ultra
performance liquid chromatography coupled with tandem mass
spectrometry (UPLC–MS/MS).
2. Methods
2.1. Chemicals
PhIP-HCl (CAS no. 105650-23-5) of 99% purity (Wako Pure
Chemical Industries Ltd., Osaka, Japan) was dissolved in saline and
adjusted to pH 3.5. Proteinase K and ribonuclease A were
purchased from Qiagen (Hilden, Germany). Calf intestine alkaline
phosphatase, micrococcal nuclease (from Staphylococcus aureus)
and calf spleen phosphodiesterase were purchased from Sigma-
Aldrich (Steinheim, Germany). HPLC-grade methanol, formic acid
and acetic acid were from Carl Roth GmbH (Karlsruhe, Germany).
The synthesis of the isotope-labelled reference standard
[15N5,13C10]C8-PhIP-dG was described previously (Lin et al., 1992).
2.2. Animals and housing
FVB mice expressing human sulfotransferases 1A1 and 1A2
(hSULT mice, termed tg1 in the original publication) have been
described previously (Dobbernack et al., 2011). Homozygous
hSULT males of 9–11 weeks of age were included in the experiment
along with male FVB wild-type mice purchased from the Jackson
Laboratories (Bar Harbour, ME, USA). Littermates were co-housed
in plastic cages on Nestpak Aspen 4HK bedding (Datesand Ltd.,
Manchester, UK) with a 12 h light/dark cycle and free access to food
(SDS RM1 maintenance diet, Special Diet Services Ltd., Witham,
UK) and tap water. The experiments were carried out in conformity
with the laws and regulations for experiments with living animalsin Norway, and were approved by the Norwegian Animal Research
Authority.
2.3. Treatment and harvest of organs
Mice were placed in individual cages the day before the
experiment. A single dose of 75 mg/kg bw PhIP or 0.9% saline was
administered by oral gavage (n = 5 for each treatment group and
strain) and mice were sacriﬁced 3 h after exposure. Liver, kidneys,
small intestine and colon were collected and rinsed in ice cold PBS.
The small intestine was divided in proximal and distal parts of
equal length. Organs were immediately snap frozen in liquid
nitrogen and stored at 80 C.
2.4. DNA isolation
A Qiagen Blood and Cell Culture DNA kit was used to isolate
DNA. G2 lysis buffer supplemented with 0.2 mg/ml ribonuclease A
was added to the frozen tissue, which was cut roughly and then
mechanically homogenated using a T10 Ultra Turrax (IKA, Staufen,
Germany). Aliquots (250–300 ml) of homogenate (equivalent to
100 mg tissue) were frozen at 80 C. Samples were thawed and
stirred gently before addition of G2 lysis buffer with 0.5 mg/ml
Proteinase K and 0.2 mg/ml ribonuclease A, to a total volume of
9.75 ml. The homogenate was incubated in a water bath for 2 h at
37 C for digestion. Samples were centrifuged at 4000g for 10 min
and DNA was isolated from the supernatant using Genomic-tip
100/G columns (Qiagen), according to the manufacturer’s protocol.
Finally, DNA was dissolved in 400 ml of distilled H2O, the
concentration was measured with a ND-1000 Nandodrop spec-
trophotometer (Thermo Scientiﬁc, Wilmington, DE, USA), and
samples were frozen at 80 C until further analysis.
2.5. Enzymatic digestion of DNA
Samples containing 100 mg DNA were dried together with
5413 fmol of the reference standard [15N5,13C10]C8-PhIP-dG. The
residues were dissolved in 56 ml water and 16 ml of 100 mM
sodium succinate (pH 6.0) containing 50 mM CaCl2. Aliquots of
12 ml calf spleen phosphodiesterase (4.0 mU/ml) and 12 ml
micrococcal nuclease (200 mU/ml) were added and the samples
were incubated for 8 h at 37 C. A volume of 38 ml 0.5 M Tris (pH
10.9) and 3 of ml shrimp alkaline phosphatase (1 U/ml) were added
and the incubation was resumed at 37 C for 14 h. The DNA digests
were diluted with 300 ml methanol. The mixture was centrifuged
and the pellet was extracted with another 400 ml of methanol.
After evaporation of the solvents the residuals were taken up in
50 ml methanol and centrifuged at 15 000g for 15 min. The
supernatant was used for mass spectrometric analysis.
2.6. Isotope dilution UPLC–MS/MS for quantiﬁcation of C8-PhIP-dG
An Acquity UPLC System (Waters, Eschborn, Germany) with an
HSS T3 column (1.8 mm, 2.1 100 mm, Waters) was used for
sample separation. Aliquots of 8 ml were injected and eluted with a
gradient of water (solvent A) and acetonitrile (solvent B). Both
eluents were acidiﬁed with 0.25% acetic acid and 0.25% formic acid.
Following a washing interval of 1 min, the content of eluent A was
decreased from at 90% to 20% within 5 min. The ﬂow rate was
0.35 ml/min. The UPLC was connected to a Quattro Premier XE
mass spectrometer (Waters) with an electrospray interface
operated in the positive ion mode. The adduct quantiﬁcation
was based on a characteristic neutral loss of the 20-deoxyribose in
the analyte and the isotope-labeled reference standard (C8-PhIP-
dG, m/z = 490.0 ! 374.0; [15N5,13C10]C8-PhIP-dG, m/
z = 505.0 ! 384.0) (Monien, 2014). The tune parameters were as
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tion temperature: 485 C; desolvation gas: nitrogen (950 l/h); cone
gas: nitrogen (50 l/h); collision gas: argon (indicated cell pressure
5103 mbar). For the fragmentation of C8-PhIP-dG the collision
energy was set to 35 eV. The dwell time was 100 ms and the
capillary voltage was 1.0 kV. The cone and RF1 lens voltages were
25 V and 0.1 V, respectively. Data acquisition and handling were
performed with MassLynx 4.1 software (Waters).
2.7. Statistical analysis
Differences between the groups were evaluated using a two
way analysis of variance on ranks, applying the Holm-Šídák
method for pairwise multiple comparison procedures, in Sigma-
Plot version 12.0 (Systat Software GmbH, Erkrath, Germany). A
p-value of 0.05 was considered signiﬁcant.
3. Results
The UPLC–MS/MS chromatograms of a DNA sample from the
liver of a PhIP exposed hSULT mouse is shown in Fig. 1.
The levels of C8-PhIP-dG adducts were signiﬁcantly higher in
PhIP exposed hSULT mice compared with exposed wt mice for all
organs tested (p < 0.001, Fig. 2). The detected amount of C8-PhIP-
dG adducts in wt mice was lowest in the liver and kidney, and
somewhat higher in the intestinal and colonic DNA (p < 0.001
– distal small intestine versus liver and kidney, P < 0.05 – intestine
versus liver, kidney and colon). In the exposed hSULT mice,
however, the level of adducts was clearly highest in the liverFig. 1. UPLC–MS/MS chromatograms of digested DNA sample from a hSULT1A1/1A2 exp
fragmentations m/z = 490.1 !374.1 (panel C) and m/z = 490.1 !250.1 (panel D) are show
chromatograms, m/z = 505.1 !384.1 (panel A) and m/z = 505.1 ! 252.1 (panel B).(p < 0.001—liver versus kidney, intestine and colon), followed by
intestinal and colonic levels (p < 0.05–intestine versus kidney),
and the number of adducts in the kidney was lowest. Comparing
the exposed hSULT mice with the wt mice, there was a 14-fold
increase in adducts in the liver, while the kidney and proximal
small intestine had a 3.0 and 3.5-fold increase, respectively, and in
the distal small intestine and colon the levels increased by just
above 2.5-fold. No C8-PhIP-dG adducts were found in unexposed
animals.
4. Discussion
The low level of PhIP adducts detected in the liver compared to
other tissues of the wt mice after oral exposure has also been
reported by others (Dobbernack et al., 2011; Snyderwine et al.,
2002), and similar results are found in rats (Kaderlik et al., 1994).
The pronounced increase in adduct formation in the hSULT mouse
compared with the wt mouse, between 2.5 and 14-fold, conﬁrms
previous ﬁndings that human SULT1As have the ability to
transform PhIP into a reactive metabolite that contribute to
genotoxicity in vivo (Dobbernack et al., 2011). The ratio between
adduct levels in the extra hepatic tissues in the hSULT mouse was
similar to those in the wt mouse, but the number of adducts was
always roughly threefold higher in the hSULT mouse. For the liver,
however, hSULT1A1 and 1A2 expression changed the adduct
formation dramatically. In the wt mice the liver was the organ with
the lowest level of adducts, whereas it was the organ with the
highest number of adducts in the hSULT mouse (14-fold increase).
The observed change in tissue distribution matches the ﬁndings ofressing FVB/N mouse treated with PhIP. The chromatograms of C8-PhIP-dG with the
n together with the parallel recording of [15N5,13C10]C8-PhIP-dG fragmentational
Fig. 2. Adduct levels detected in DNA isolated from organs of FVB males with (hSULT mice) or without (wt) hSULT1A2 and 1A2 exposed to one oral dose of 75 mg/kg PhIP.
Figure shows mean and SD of 5 mice. (*** p < 0.001). No C8-PhIP-dG adducts were found in unexposed animals.
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adducts also relates well to the concentration of expressed
hSULT1A1 enzyme in the different tissues of the hSULT mouse
reported in the same paper, even though that study used
hemizygous animals, in contrast to the homozygous animals in
the present work.
Quantitation of C8-PhIP-dG in wt and hSULT mice after oral
exposure of PhIP using UPLC–MS/MS yielded comparable results as
those obtained using traditional 32P-postlabelling methodology
(Dobbernack et al., 2011). One noticeable difference between the
results, however, is that the adduct levels in the present work are
approximately 10 times higher than the levels found in the
previous study, even though the administered dose applied in the
present experiment is lower (75 mg/kg bw instead of 90 mg/
kg bw). This discrepancy can be explained by three factors, namely
(i) different time point for adduct analyses (3 versus 8 h) after PhIP
exposure (ii) the fact that the present study used homozygous
animals compared to hemizygous in the previous, and (iii) the
tendency of underestimation by the 32P-postlabelling method used
in the previous study. The different time point of adduct analysis
between the present study and the study by Dobbernack et al.
(2011) is not likely to be an explanation for the difference in adduct
levels as considerable repair of PhIP adducts has been shown to
take several days (Steffensen et al., 2005). If homozygosity was the
sole explanation, one should only expect a doubling of the number
of adducts, consequently methodological aspects are likely to be
important as well. The risk of underestimation using the 32P-
postlabelling method is based on the possibility of incomplete
digestion of DNA and subsequent insufﬁcient incorporating of
labelled [32P]phosphoryl groups. One also risks partial phosphor-
ylation of the modiﬁed nucleotides, which will then escape
detection (Monien, 2014). However, using the heterozygous hSULT
mice might be preferable when using the 32P-postlabelling
method. Overall, the UPLC–MS/MS is the preferred method for
determining exact concentrations of chemically deﬁned adducts,
and strengthens the credibility of the present work.
In conclusion, the results obtained from this study conﬁrm that
human enzymes hSULT1A1 and 1A2 efﬁciently convert PhIP into areactive metabolite and conﬁrms the altered tissue distribution of
DNA adducts in the presence of hSULTs. UPLC–MS/MS technology
proves to be a reproducible and well suited method for sensitive
detection of C8-PhIP-dG adducts.
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